Study Evaluating the Safety and Feasibility of Platelet-rich Plasma to Treat Facetogenic Low Back Pain
Stopped Projected cost to continue was not supported by the study budget and additional funds could not be obtained so the decision to close the study was made.
Conditions
Interventions
- DEVICE: Angel® Concentrated Platelet Rich Plasma System
- DRUG: Platelet Rich Plasma
Sponsor
Matthew Pingree